Correlation Between Bio Path and Cumberland Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bio Path and Cumberland Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Cumberland Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Cumberland Pharmaceuticals, you can compare the effects of market volatilities on Bio Path and Cumberland Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Cumberland Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Cumberland Pharmaceuticals.
Diversification Opportunities for Bio Path and Cumberland Pharmaceuticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bio and Cumberland is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Cumberland Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cumberland Pharmaceuticals and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Cumberland Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cumberland Pharmaceuticals has no effect on the direction of Bio Path i.e., Bio Path and Cumberland Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bio Path and Cumberland Pharmaceuticals
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Cumberland Pharmaceuticals. In addition to that, Bio Path is 1.76 times more volatile than Cumberland Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Cumberland Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest 128.00 in Cumberland Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 9.00 from holding Cumberland Pharmaceuticals or generate 7.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bio Path Holdings vs. Cumberland Pharmaceuticals
Performance |
| Timeline |
| Bio Path Holdings |
| Cumberland Pharmaceuticals |
Bio Path and Cumberland Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Path and Cumberland Pharmaceuticals
The main advantage of trading using opposite Bio Path and Cumberland Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Cumberland Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cumberland Pharmaceuticals will offset losses from the drop in Cumberland Pharmaceuticals' long position.| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
| Cumberland Pharmaceuticals vs. Phibro Animal Health | Cumberland Pharmaceuticals vs. Procaps Group SA | Cumberland Pharmaceuticals vs. Amphastar P | Cumberland Pharmaceuticals vs. Alkermes Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |